Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

AMP-303 safely increases hair growth in men with hair loss.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Allopregnanolone changes gene expression in glioblastoma cells.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Delgocitinib cream may help treat frontal fibrosing alopecia.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

A group has developed therapies that show promise for treating cancer and various other conditions.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.